Rituximab Plus Bortezomib for Relapsed and Refractory Warm Autoimmune Hemolytic Anemia: A Prospective Phase 2 Trial

Am J Hematol. 2024 Dec 21. doi: 10.1002/ajh.27540. Online ahead of print.

Authors

Xijuan Lin¹, Chen Yang¹, Junling Zhuang¹, Jian Li¹, Daobin Zhou¹, Miao Chen¹, Bing Han¹

Affiliation

¹ Department of Hematology, Peking Union Medical College Hospital and Chinese Academy of Medical Sciences, Beijing, China.

PMID: 39708374
DOI: 10.1002/ajh.27540

No abstract available

Publication types

Letter

Grants and funding